+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Europe Infectious Respiratory Disease Diagnostics Market Size, Share & Industry Trends Analysis Report by Product Type, Application, Sample Type, Technology, End-use, Country and Growth Forecast, 2022-2028

  • PDF Icon

    Report

  • 155 Pages
  • September 2022
  • Region: Europe
  • Marqual IT Solutions Pvt. Ltd (KBV Research)
  • ID: 5673982
The Europe Infectious Respiratory Disease Diagnostics Market would witness market growth of -5.6% CAGR during the forecast period (2022-2028).

The clinical presentation of the patient and a number of diagnostic assays are used in current methods of diagnosis and surveillance. This could be difficult, though, because the clinical presentation for respiratory infections is sometimes insufficient for identification due to overlapping symptoms. Over the past few years, laboratory diagnosis of respiratory infections has advanced significantly, enabling prompt and useful results to be given to patients.

In recent years, laboratory diagnostic testing for respiratory tests has developed quickly. Direct fluorescent antigen (DFA) testing, quick serological assays, conventional microbiological respiratory cultures, and pathogen-specific molecular assays are only a few of the numerous methods and assays used in laboratories. Each has a specific function and is essential to the lab.

Numerous conventional testing techniques, such as culture, DFA, and quick testing, are arbitrary and reliant on the approach and experience of the user. Additionally, DFA is subjected to suitable lower respiratory tract digestion and photobleaching. The turnaround time of these traditional techniques is another drawback. Many conventional techniques could take several hours to accomplish, let alone days or weeks. Rapid serology-based assays are on the other end of the spectrum. These rapid assays, whether used at the point of care or in the lab, provide a quick check to see if a specific pathogen is present. Positives are often verified using traditional microbiology techniques. Rapid tests offer a rapid screening but are less sensitive than traditional microbiological.

Over the projected period, Europe is anticipated to experience a significant growth rate. The rising emergence of respiratory indications as well as rising testing rates is both responsible for the region's expansion. The NHS experiences significant pressures during the winter because of respiratory diseases; the majority of these admissions are non-elective and more than double during this time. A large number of people in the region are affected by respiratory disease, which is the third leading cause of death there (after cancer and cardiovascular disease).

The Germany market dominated the Europe Infectious Respiratory Disease Diagnostics Market by Country in 2021; thereby, achieving a market value of $2.4 billion by 2028. The UK market is exhibiting a CAGR of -6.4% during (2022-2028). Additionally, The France market would showcase a CAGR of -4.9% during (2022-2028).

Based on Product Type, the market is segmented into Consumables, Instruments (Imaging Tests, Respiratory Measurement Devices, and Others), Services. Based on Application, the market is segmented into SARS/COVID 19, Influenza, RSV (Respiratory Syncytial Virus), Tuberculosis, Streptococcus Testing, and Others. Based on Sample Type, the market is segmented into Saliva, Anterior Nasal Region, Blood, Nasopharyngeal Swabs (NPS), and Others. Based on Technology, the market is segmented into Molecular Diagnostics, Microbiology, Immunoassay, and Others. Based on End-use, the market is segmented into Diagnostic Laboratories, Hospitals, and Physician Offices & Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Becton, Dickinson and Company, Siemens Healthineers AG (Siemens AG), Thermo Fisher Scientific, Inc., Koninklijke Philips N.V., F. Hoffmann-La Roche Ltd., Qiagen N.V., Bio-Rad Laboratories, Inc., Danaher Corporation, Quidel Corporation

Scope of the Study

Market Segments Covered in the Report:

By Product Type

  • Consumables
  • Instruments
  • Imaging Tests
  • Respiratory Measurement Devices
  • Others
  • Services

By Application

  • SARS/COVID 19
  • Influenza
  • RSV (Respiratory Syncytial Virus)
  • Tuberculosis
  • Streptococcus Testing
  • Others

By Sample Type

  • Saliva
  • Anterior Nasal Region
  • Blood
  • Nasopharyngeal Swabs (NPS)
  • Others

By Technology

  • Molecular Diagnostics
  • Microbiology
  • Immunoassay
  • Others

By End Use

  • Diagnostic Laboratories
  • Hospitals
  • Physician Offices & Others

By Country

  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe

Key Market Players

List of Companies Profiled in the Report:

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Siemens Healthineers AG (Siemens AG)
  • Thermo Fisher Scientific, Inc.
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Quidel Corporation

Unique Offerings from the Publisher

  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 Europe Infectious Respiratory Disease Diagnostics Market, by Product Type
1.4.2 Europe Infectious Respiratory Disease Diagnostics Market, by Application
1.4.3 Europe Infectious Respiratory Disease Diagnostics Market, by Sample Type
1.4.4 Europe Infectious Respiratory Disease Diagnostics Market, by Technology
1.4.5 Europe Infectious Respiratory Disease Diagnostics Market, by End Use
1.4.6 Europe Infectious Respiratory Disease Diagnostics Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. Competition Analysis - Global
3.1 Cardinal Matrix
3.2 Recent Industry Wide Strategic Developments
3.2.1 Partnerships, Collaborations and Agreements
3.2.2 Product Launches and Product Expansions
3.2.3 Acquisition and Mergers
3.2.4 Geographical Expansion
3.2.5 Approval & Trails:
3.3 Top Winning Strategies
3.3.1 Key Leading Strategies: Percentage Distribution (2018-2022)
3.3.2 Key Strategic Move: (Product Launches and Product Expansions: 2020, Mar - 2022, Jun) Leading Players
Chapter 4. Europe Infectious Respiratory Disease Diagnostics Market by Product Type
4.1 Europe Consumables Market by Country
4.2 Europe Instruments Market by Country
4.3 Europe Infectious Respiratory Disease Diagnostics Market by Instruments Type
4.3.1 Europe Imaging Tests Market by Country
4.3.2 Europe Respiratory Measurement Devices Market by Country
4.3.3 Europe Others Market by Country
4.4 Europe Services Market by Country
Chapter 5. Europe Infectious Respiratory Disease Diagnostics Market by Application
5.1 Europe SARS/COVID 19 Market by Country
5.2 Europe Influenza Market by Country
5.3 Europe RSV (Respiratory Syncytial Virus) Market by Country
5.4 Europe Tuberculosis Market by Country
5.5 Europe Streptococcus Testing Market by Country
5.6 Europe Others Market by Country
Chapter 6. Europe Infectious Respiratory Disease Diagnostics Market by Sample Type
6.1 Europe Saliva Market by Country
6.2 Europe Anterior Nasal Region Market by Country
6.3 Europe Blood Market by Country
6.4 Europe Nasopharyngeal Swabs (NPS) Market by Country
6.5 Europe Others Market by Country
Chapter 7. Europe Infectious Respiratory Disease Diagnostics Market by Technology
7.1 Europe Molecular Diagnostics Market by Country
7.2 Europe Microbiology Market by Country
7.3 Europe Immunoassay Market by Country
7.4 Europe Others Market by Country
Chapter 8. Europe Infectious Respiratory Disease Diagnostics Market by End-use
8.1 Europe Diagnostic Laboratories Market by Country
8.2 Europe Hospitals Market by Country
8.3 Europe Physician Offices & Others Market by Country
Chapter 9. Europe Infectious Respiratory Disease Diagnostics Market by Country
9.1 Germany Infectious Respiratory Disease Diagnostics Market
9.1.1 Germany Infectious Respiratory Disease Diagnostics Market by Product Type
9.1.1.1 Germany Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.1.2 Germany Infectious Respiratory Disease Diagnostics Market by Application
9.1.3 Germany Infectious Respiratory Disease Diagnostics Market by Sample Type
9.1.4 Germany Infectious Respiratory Disease Diagnostics Market by Technology
9.1.5 Germany Infectious Respiratory Disease Diagnostics Market by End-use
9.2 UK Infectious Respiratory Disease Diagnostics Market
9.2.1 UK Infectious Respiratory Disease Diagnostics Market by Product Type
9.2.1.1 UK Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.2.2 UK Infectious Respiratory Disease Diagnostics Market by Application
9.2.3 UK Infectious Respiratory Disease Diagnostics Market by Sample Type
9.2.4 UK Infectious Respiratory Disease Diagnostics Market by Technology
9.2.5 UK Infectious Respiratory Disease Diagnostics Market by End-use
9.3 France Infectious Respiratory Disease Diagnostics Market
9.3.1 France Infectious Respiratory Disease Diagnostics Market by Product Type
9.3.1.1 France Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.3.2 France Infectious Respiratory Disease Diagnostics Market by Application
9.3.3 France Infectious Respiratory Disease Diagnostics Market by Sample Type
9.3.4 France Infectious Respiratory Disease Diagnostics Market by Technology
9.3.5 France Infectious Respiratory Disease Diagnostics Market by End-use
9.4 Russia Infectious Respiratory Disease Diagnostics Market
9.4.1 Russia Infectious Respiratory Disease Diagnostics Market by Product Type
9.4.1.1 Russia Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.4.2 Russia Infectious Respiratory Disease Diagnostics Market by Application
9.4.3 Russia Infectious Respiratory Disease Diagnostics Market by Sample Type
9.4.4 Russia Infectious Respiratory Disease Diagnostics Market by Technology
9.4.5 Russia Infectious Respiratory Disease Diagnostics Market by End-use
9.5 Spain Infectious Respiratory Disease Diagnostics Market
9.5.1 Spain Infectious Respiratory Disease Diagnostics Market by Product Type
9.5.1.1 Spain Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.5.2 Spain Infectious Respiratory Disease Diagnostics Market by Application
9.5.3 Spain Infectious Respiratory Disease Diagnostics Market by Sample Type
9.5.4 Spain Infectious Respiratory Disease Diagnostics Market by Technology
9.5.5 Spain Infectious Respiratory Disease Diagnostics Market by End-use
9.6 Italy Infectious Respiratory Disease Diagnostics Market
9.6.1 Italy Infectious Respiratory Disease Diagnostics Market by Product Type
9.6.1.1 Italy Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.6.2 Italy Infectious Respiratory Disease Diagnostics Market by Application
9.6.3 Italy Infectious Respiratory Disease Diagnostics Market by Sample Type
9.6.4 Italy Infectious Respiratory Disease Diagnostics Market by Technology
9.6.5 Italy Infectious Respiratory Disease Diagnostics Market by End-use
9.7 Rest of Europe Infectious Respiratory Disease Diagnostics Market
9.7.1 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Product Type
9.7.1.1 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Instruments Type
9.7.2 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Application
9.7.3 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Sample Type
9.7.4 Rest of Europe Infectious Respiratory Disease Diagnostics Market by Technology
9.7.5 Rest of Europe Infectious Respiratory Disease Diagnostics Market by End-use
Chapter 10. Company Profiles
10.1 Abbott Laboratories
10.1.1 Company Overview
10.1.2 Financial Analysis
10.1.3 Segmental and Regional Analysis
10.1.4 Research & Development Expense
10.1.5 Recent strategies and developments:
10.1.5.1 Product Launches and Product Expansions:
10.1.5.2 Acquisition and Mergers:
10.1.6 SWOT Analysis
10.2 Becton, Dickinson and Company
10.2.1 Company Overview
10.2.2 Financial Analysis
10.2.3 Segmental and Regional Analysis
10.2.4 Research & Development Expense
10.2.5 Recent strategies and developments:
10.2.5.1 Partnerships, Collaborations, and Agreements:
10.2.5.2 Product Launches and Product Expansions:
10.2.6 SWOT Analysis
10.3 Siemens Healthineers AG (Siemens AG)
10.3.1 Company Overview
10.3.2 Financial Analysis
10.3.3 Segmental and Regional Analysis
10.3.4 Research & Development Expense
10.3.5 Recent strategies and developments:
10.3.5.1 Partnerships, Collaborations, and Agreements:
10.3.5.2 Acquisitions and Mergers:
10.3.5.3 Geographical Expansions:
10.3.6 SWOT Analysis
10.4 Thermo Fisher Scientific, Inc.
10.4.1 Company Overview
10.4.2 Financial Analysis
10.4.3 Segmental and Regional Analysis
10.4.4 Research & Development Expense
10.4.5 Recent strategies and developments:
10.4.5.1 Partnerships, Collaborations, and Agreements:
10.4.5.2 Product Launches and Product Expansions:
10.5 Koninklijke Philips N.V.
10.5.1 Company Overview
10.5.2 Financial Analysis
10.5.3 Segmental and Regional Analysis
10.5.4 Research & Development Expense
10.5.5 Recent strategies and developments:
10.5.5.1 Partnerships, Collaborations, and Agreements:
10.6 F. Hoffmann-La Roche Ltd.
10.6.1 Company Overview
10.6.2 Financial Analysis
10.6.3 Segmental and Regional Analysis
10.6.4 Research & Development Expense
10.6.5 Recent strategies and developments:
10.6.5.1 Product Launches and Product Expansions:
10.7 Qiagen N.V.
10.7.1 Company Overview
10.7.2 Financial Analysis
10.7.3 Regional Analysis
10.7.4 Research & Development Expense
10.7.5 Recent strategies and developments:
10.7.5.1 Product Launches and Product Expansions:
10.8 Bio-Rad laboratories, Inc.
10.8.1 Company Overview
10.8.2 Financial Analysis
10.8.3 Segmental and Regional Analysis
10.8.4 Research & Development Expenses
10.8.5 Recent strategies and developments:
10.8.5.1 Product Launches and Product Expansions:
10.9 Danaher Corporation
10.9.1 Company Overview
10.9.2 Financial Analysis
10.9.3 Segmental and Regional Analysis
10.9.4 Research & Development Expense
10.9.5 Recent strategies and developments:
10.9.5.1 Acquisitions and Mergers:
10.10. Quidel Corporation
10.10.1 Company Overview
10.10.2 Financial Analysis
10.10.3 Regional Analysis
10.10.4 Research & Development Expense
10.10.5 Recent strategies and developments:
10.10.5.1 Approvals & Trails:

Companies Mentioned

  • Abbott Laboratories
  • Becton, Dickinson and Company
  • Siemens Healthineers AG (Siemens AG)
  • Thermo Fisher Scientific, Inc.
  • Koninklijke Philips N.V.
  • F. Hoffmann-La Roche Ltd.
  • Qiagen N.V.
  • Bio-Rad Laboratories, Inc.
  • Danaher Corporation
  • Quidel Corporation

Methodology

Loading
LOADING...